Chelsi Strategene

Although this report may provide useful diagnostic information, by providing this report,
drbenlynch.com (DBL) does not make or suggest any specific diagnosis or therapeutic course of
treatment or action. Any such diagnosis and/or treatment/ therapeutic plan is strictly a matter
between the patient and his or her health care professional.
In order to receive advice with regard to how to use the information in this document, please see
the Directory, which is a directory of healthcare practitioners who have taken Dr. Ben Lynch's
courses. There is also a Facebook group, which purchasers of StrateGene are welcome to join.
Prepared For: C010232018

Report Time: 10/23/18 UTC
Raw Data Extraction Date: 10/23/18
StrateGene: v1.19 ( Version History )
Current Bibliography: http://strategene.org/bibliography/
Go To:
Overview | Folate | Methionine | Transsulfuration | Biopterin | Histamine | Bonus | FAQ | Glossary
Symbols and Colors
Cofactor
Gene/Enzyme
Increases Activity Decreases Activity
Gene/Enzyme Gene/Enzyme Gene/Enzyme Gene/Enzyme
No SNP Data Wild Type Heterozygous SNP Homozygous SNP
StrateGene | Overview | Folate | Methionine | Transsulfuration | Biopterin | Histamine | Bonus | FAQ | Glossary
Copyright © 2016-2018 Dr. Ben Lynch. All Rights Reserved.
C010232018 Section 1: Overview Page 2 of 16
Section 1: Overview
Core SNPs
RS# Call Risk Allele Gene Variation Result
rs1051266 CT T SLC19a1 G80A +/-
rs2236225 AA A MTHFD1 G1958A +/+
rs1801131 TT G MTHFR A1298C -/-
rs1801133 GG A MTHFR C677T -/-
rs1801394 AG G MTRR A66G +/-
rs1532268 CT T MTRR C524T +/-
rs72558181 NA T MAT1A R264H NA
rs28934891 CC T CBS D444N -/-
rs4920037 GG A CBS C19150T -/-
rs234706 GG A CBS C699T -/-
rs4880 AG A SOD2 A16V +/-
rs1799895 NA G SOD3 Ex3-631C>G NA
rs1695 AA G GSTP1 Ile105Val -/-
rs1138272 CC T GSTP1 A114V -/-
rs1050828 CC T G6PD G202A -/-
rs1050829 TT C G6PD A376G -/-
rs5030868 GG A G6PD C563T (Medit.) -/-
rs1050450 NA A GPX1 Pro199Leu NA
rs1800783 NA A NOS3/eNOS -1495A>T NA
rs1800779 AG G NOS3/eNOS A(-922)G +/-
i6018900 NA T SULT1A1 638G>A NA
rs6323 NA G MAOA T941G NA
rs1137070 NA T MAOA 1410T>C NA
rs1799836 NA C MAOB NA
rs4680 AG A COMT V158M +/-
rs4633 CT T COMT H62H +/-
rs10156191 NA T AOC1 (DAO) Thr16Met NA
-/- = not present; +/- = one mutation; +/+ = double mutation; +/+* = mutation on the X chromosome in a male.
Predicted NAT2 acetylator phenotype with probability estimate: SLOW (0.998731)
Note: Your genetics testing company didn't check for GSTT1 SNPs in your sample, so the possibility
of a GSTT1 deletion polymorphism could not be assessed.
C010232018 Bonus SNPs Page 3 of 16
Bonus SNPs
RS# Call Risk Allele Gene Variation Result
rs12934922 AT T BCO1 R267S +/-
rs7501331 CC T BCO1 A379V -/-
rs6420424 AG A BCO1 (PKD1L2) C754T +/-
rs11645428 AG G BCO1 +/-
rs6564851 GT G BCO1 +/-
rs601338 GG A FUT2 -/-
rs1800566 AG A NQO1 +/-
rs1800562 GG A HFE C282Y -/-
rs1799945 CG G HFE H63D +/-
rs1800730 -- T HFE Ser65Cys NC
rs7946 TT T PEMT 5465G>A +/+
rs174537 GG G FADS1 (MYRF) +/+
rs174548 CC G FADS1 -/-
rs1535 AA G FADS2 -/-
rs1800629 GG A TNF-alpha -/-
rs34637584 GG A LRRK2 2109S -/-
rs2228570 NA G VDR Fok1 NA
rs731236 AA G VDR Taq1 -/-
rs1544410 CC T VDR Bsm1 -/-
rs7412 CC C APOE Arg176Cys +/+
rs429358 CT C APOE +/-
-/- = not present; +/- = one mutation; +/+ = double mutation; +/+* = mutation on the X chromosome in a male.
C010232018 2.1 The Folate Cycle Page 4 of 16
Section 2: Results
2.1 The Folate Cycle
For life to occur, the folate cycle must be functioning. There are three major aspects of this
biochemical cycle. First, components of energy via ATP and GTP are needed. Folate provides the
building blocks for ATP synthesis. Secondly, folate provides the building blocks for DNA bases.
Thirdly, folate feeds into the methylation cycle, thereby supporting methylation. If the folate cycle
is not functioning optimally, dysfunction in the areas of energy generation, DNA synthesis/repair
and methylation occurs.
Reduced Folates and Folic Acid

(uncooked leafy greens)
Retinoic acid
FOLR1 FOLR2 SLC
Folic acid, Dairy antibodies NADPH Folic acid
DHFR Unmetabolized Folic Acid
DHF Folic Acid, EGCG, GSE,

Methotrexate, Sulfasalazine and Bactrim
ROS, Infection,
Rapid cell division DHFR
Thymidine dTMP organophosphates, NADP

(DNA Replication 5-FU THF
TYMS
and Repair) Formate
dUMP ATP, GTP ATP
Purines MTHFD1 Serine

Adenosine
Guanosine SHMT
10-Formyl THF
Sufficient Ferritin, UV-radiation NADPH Low Methionine
B6 Glycine
B6 NADP NO, Pb, Hg, H 2 0 2 ,
THF MTHFD1 MTR Acetylaldehyde,
SHMT
Nitrous Oxide,
Zn TNF-α ,Cd, Al, Cu,
5-Formyl
Mg,ATP 5,10-Methenyl THF EtOH,
THF * NADPH
NADP
MTHFS MTHFD1
10-formyl THF 5-MTHF *
5,10-Methylene THF
FAD, NADPH
MTHFR
DHA, Low Methionine, ALA SAM, CDR, ROS,

DHF, sulfasalazine, folic acid *Leafy Greens
C010232018 2.1 The Folate Cycle Page 5 of 16
2.1.1 FOLATE CYCLE SNPS
SLC19A1
The SLC19a1 (Solute carrier family 19) gene expresses the major reduced folate transporter in
mammalian tissues and cells. This transports both folates and antifolates, such as methotrexate,
from systemic circulation and maintains intracellular levels of folate.
Factors influencing SLC19a1:

i Folic acid, Zinc, EtOH, pH below 6.5
h pH near 7.4 (normal blood pH); erythropoietin; Vitamin D
SNP(s) Found:
SLC19a1 G80A (+/-, CT) ~50% i
▪ This variant has been found to reduce 5-formyl tetrahydrofolate transport by 50%.
▪ Associated symptoms and conditions may be increased risk for acute leukemias. (The SNP
may also confer a protective effect against gastric cancer.)
MTHFD1
The MTHFD1 (Methylenetetrahydrofolate dehydrogenase 1) gene expresses a trifunctional enzyme
that interconverts tetrahydrofolate (THF) derivatives for nucleotide synthesis in the cytoplasm. THF
is important in the de novo synthesis of purines and thymidylate and in the regeneration of
methionine from homocysteine.
Factors influencing MTHFD1:

Cofactor: Mg-ATP
SNP(s) Found:
MTHFD1 G1958A (+/+, AA) ~34% i
▪ This variant has been found to reduce the metabolic activity of MTHFD1 within murine
cells by up to 34%.
▪ Associated symptoms and conditions may be choline deficiency with related dysfunction
(e.g., fatty liver), neural tube defects, and placental abruption. AA and AG women should
consider supplementing with choline before and during pregnancy, and after menopause.
C010232018 2.2 The Methionine Cycle Page 6 of 16
2.2 The Methionine Cycle

The methionine cycle's main feature is the recycling of homocysteine back into SAMe. Since SAMe is
the primary methyl donor in numerous biochemical processes in the body, it is critically important
that the methionine cycle functions properly. If the methionine cycle is dysfunctional, methylation
becomes inhibited and homocysteine levels may increase. The inhibition of SAMe production and/or
utilization leads to significant biochemical disturbances. Evaluating methionine cycle function
provides a foundation towards identifying the individual's ability to not only produce SAMe but also
to utilize it.
NO, LPS, CCL4,

Hep B, Hep C, Pyruvate
Mg, ATP TNF- , CDR, Putrescine
IL-6, DHA SAMDC dcSAM
Methionine
MAT1A Spermine, Spermidine
SAM Cortisol
Fasting, Low methionine
5-MTHF, Growth CH3
FAD Methyltransferases
Hormones a) 70% + SAM Utilization PEMT and GAMT
b) DMNT CpG Sites
DMGDH Sarcosine GNMT
SAH, BPA, EGCG, Pb
Polyphenols (Tea & Coffee),
Cob(I)alamin Vitamin A, SAH Chlorogenic Acid
Cob(II)alamin
Glucocorticoids
DMG
O 2- Zn
Glycine
Low Methionine BHMT
Methylthioadenosine Mg
H2 O 2
NO, Pb, Hg, H 2 0 2 , Betaine
MTR Cortisol, High Fasting/ NT5C
Acetylaldehyde, MTRR Methionine Starvation,
Nitrous Oxide,
Zn SAM, FAD, NAD PGC-1α AHCY Adenosine ADK AK ATP
TNF-α ,Cd, Al, Cu, AMP
EtOH, Mg
NAD ADA
DPPIV Mg DHA,
Methylcobalamin Zn ADCY
Arsenate
NH 3
forskolin
Inosine
cAMP
Ca Hypoxanthine
Homocysteine
Choline
PON1 B6, Serine O 2- Mb
High cysteine, Oxidized LDL,
Homocysteine thiolactone XO
Testosterone, CBS High SAM, Zn, Ang II,CRP, ROS
Low SAM Low cysteine, H 2O2
Uric Acid
C010232018 2.2 The Methionine Cycle Page 7 of 16
2.2.1 METHIONINE CYCLE SNPS
MTRR
The MTRR (Methionine synthase reductase) gene expresses the enzyme needed to restore oxidized
cobalamin(II) to CH3-cobalamin(III) in order to maintain the enzymatic activity of MTR (methionine
synthase). MTR, in turn, is responsible for maintaining ample tetrahydrofolate and methionine pools
in the cell, which is vital for cellular methylation.
Factors influencing MTRR:

Cofactors: FAD, FMN
i Oxidative stress
h IGF-1, dopamine
SNP(s) Found:
MTRR A66G (+/-, AG) i
▪ This variant causes a lower affinity of MTRR for the substrate methionine synthase (MTR).
▪ Associated symptoms and conditions may be altered blood or plasma levels of
homocysteine, folate, or vitamin B12 in some but not all studies. (Coexistence with MTHFR
C677TT genotype may raise homocysteine more than MTHFR C677TT alone.) Birth defects:
Neural tube defects when cobalamin status is low or when MTHFR C677TT is present,
Down syndrome, Ventricular Septal Defect (VSD/CHD). Higher risk for meningioma.
MTRR C524T (+/-, CT) i
▪ This variant causes a lower affinity of MTRR for the substrate methionine synthase (MTR).
▪ Associated symptoms and conditions may be Ventricular Septal Defect (VSD/CHD) and
schizophrenia (for the heterozygous variant).
C010232018 2.3 The Transsulfuration Pathway Page 8 of 16
2.3 The Transsulfuration Pathway

The utilization and regulation of cysteine levels are the primary objectives for the transsulfuration
pathway. Homocysteine provides the highly needed cysteine substrate for glutathione, taurine,
sulfate, hydrogen sulfide and some Krebs Cycle intermediates. If sufficient cofactors are available
and if epigenetic factors are favorable, cysteine can participate in this process. On the other hand,
when the amount of cysteine exceeds the level needed to synthesize substrate, it must be
eliminated as it is harmful in high amounts. Dysfunction in the transsulfuration pathway contributes
to a myriad of symptoms and conditions.
Ca
Mg
PON1 Homocysteine
B6, Serine NT5C
High cysteine,
Testosterone, CBS High SAM, Zn, ROS AHCY Adenosine ADK AMP AK ATP
Low SAM, Low cysteine, H 2O2
High levels GSH, Mg
Isoleucine Low ROS DPPIV ADA Mg
Cystathionine DHA,
ATP, Biotin degradation NADH, CoA, NAD Arsenate ADCY
Zn NH
TNF-α, DHA High homocysteine 3
forskolin
Methylmalonyl CoA PCCA Propionyl-CoA BCKDH α -Ketobutyrate CTH NH 4 Inosine
cAMP
O 2, Fe 2 O 2, Fe
Adenosylcobalamin TNF B6
MUT
CDO1 Cysteine Cystine RNS Hypoxanthine
B6
Succinyl CoA 2-oxoglutarate O 2- Mb
Oxidized LDL,
GOT1 XO
ATP, Mn, Mg, Glutamate Ang II,CRP, ROS
L-glutamate CSAD High cysteine, ROS; insulin,
Kreb Cycle ONOO-
(See Glucose Planner) B6 hydrocortisone, lipid peroxidation, GCL Uric Acid
H 2O Estrogen, NRF2, TNF-α , NF-KB TGF-β 1,
Taurine
mycotoxins
γ -Glutamylcysteine NO
Negative
Estrogen, feedback 0 -
Pyruvate NADPH 2
(See Glucose Planner) Mb, O 2 , H2 O GSS TNF-α
NF-kb, Nrf2 O 2- NOX
SUOX H 2O 2 ATP, Mg, Glycine
As, W LPS, IL-1 a, SOD, PGI 2
Glutathione TNF-α Mn, Cu, Zn
ATP Sulfate (GSH)
SOD
Omega 3
PAPSS As, RNS
Urine NADP+
Glutamic acid GSR Se
G6PD H2 O MPO HOCI
GST 2
ATP NADPH GPX Quercetin
FAD
PAPSS OPLAH Cu, Fe
CAT
H2O
Glutathione Cu, Fe,
5-oxoproline (GSSG) Fe, NADP
PAPS Hg, Zn
(Sulfation Support)
Amino acid
(See Biopterin Planner) exported from cell
GGCT Amino acid
GGT ROS
γ -Glutamyl-amino acid
Cysteinyl-glycine
DP
Cysteine + Glycine
C010232018 2.3 The Transsulfuration Pathway Page 9 of 16
2.3.1 TRANSSULFURATION PATHWAY SNPS
SOD2
The SOD2 (superoxide dismutase 2) gene encodes a mitochondrial protein that serves as an
important defense against superoxide radicals by converting them to hydrogen peroxide.
Factors influencing SOD2:

Cofactors: Mn2+ (Note: Mn3+ can increase ROS and is toxic, as do supraphysiological levels of Mn2+)
i Selenium, IGF-1
h LPS, IL-1a, TNF-alpha, exercise, high MUFA/Mediterranean diet, EtOH, high ROS, vitamin C,
sulforaphane, melatonin.
NOTE: SOD2 A16V (rs4880) below is a good example of a "trade-off" SNP where the
"risk" allele, as well as wild or ancestral allele, can be found to be epidemiologically
risky or beneficial depending on environmental/epigenetic factors. (See the FAQ for
more information.)
SNP(s) Found:
SOD2 A16V (+/-, AG) ih ?
▪ This variant may imply intermediate activity relative to AA and GG.
▪ Associated symptoms and conditions may be osteoporosis, higher total oxidant stress
(found in East Asians), accoustic neuroma, more toxic effects from high levels of iron, and
earlier onset of symptoms in Wilsons Disease due to potentiated toxicity of copper.
C010232018 2.4 The Biopterin Pathway Page 10 of 16
2.4 The Biopterin Pathway

Biopterin is an essential cofactor for neurotransmission and nitric oxide production. The synthesis
of dopamine, serotonin, melatonin, norepinephrine, epinephrine and nitric oxide are dependent
upon healthy biopterin levels. Neurotransmission and nitric oxide synthesis is negatively affected
when oxidized biopterin is not reduced, or substrates and other cofactors are deficient. Evaluating
the biopterin pathway allows for an understanding of how the common neurotransmitters and
nitric oxide are formed and metabolized.
AI
NADPH
DHPR
Biopterin Recycling
B6
DHFR SAM, Mg
ROS
BH4 NADPH BH 2 DDC 3-Methoxytyramine
BH 4, Fe COMT
Fe Dopamine H 20 2
Phenylalanine PAH Tyrosine FAD
Calm, IL-4, IL-10 Vit C NAD,B1
INF-g, LPS, Stress, BH 4, Fe DBH SAM
IDO1 TNF-α MAO
Serotonin HVA
Tyrosine TH L-DOPA Cu2, PQQ PAPS
SAM, Mg Norepinephrine
Kyurenine Kyurenic Acid BH 4, Fe SULT1A3 Dopamine 3-0 Sulfate
Feedback Inhibition (Protective) COMT
Tryptophan TPH 5-HTP PNMT H 20 2
3-hyproxyanthranillic Acid Estrogen, COUPLED
MAO
NADPH SAM FAD
(Free Radical Generator)
Picolinic Acid Arginine eNOS NO + Citrulline Epinephrine 3,4 DHPGA
(Neuroprotectant) NAD, B1
Quinolinic Acid SAM,Mg
(Excitotoxin + NMDA) BH 4, Fe, FAD, Ca
COMT ALDH2
Arginine Normetanephrine Serotonin PTM
02
NAD ADMA Metanephrine 3,4-DHM
Uncoupled SAM, Mg
GSSG: GSH
NOS FAD
Methylfolate
B6 COMT
BH4 MAO
H 20 2
PAPS DDC
B5
3-Methoxy-4HPGA
Serotonin
SULT1A3 Serotonin AANAT NAD, B1
O-Sulfate
H 20 2 ALDH3A2
Flame retardant, MAO
PTM
BPA, Triclosan N-acetylserotonin
NADH,B1 FAD SAM VMA
5-HIA
NAD, B1
ADH1B ASMT
ALDH2
PAPS PTM Melatonin
SULT1A1
5-HIAA
SULT1A2
UDP
5-HTS
5-HTG
2.4.1 BIOPTERIN PATHWAY SNPS
NOS3 (eNOS)
The NOS3/eNOS (Nitric oxide synthase 3, endothelial) gene product, eNOS, regulates production of
nitric oxide (NO) in endothelial blood vessel cells. The gasotransmitter NO, produced by eNOS,
inhibits platelet aggregation, results in relaxation and inhibition of cell proliferation of endothelial
smooth muscle, stimulates angiogenesis, acts as an anti-inflammatory, and prevents oxidative
damage.
Factors influencing NOS3 (eNOS):

Cofactors: Heme, FAD, FMN, tetrahydrobiopterin (BH4)
i TNF-alpha, low arginine, low BH4, low methylfolate, high ADMA, high GSSG (oxidized
glutathione), high peroxynitrate, and a "SAD"-diet (a diet high in fat and refined carbohydrates)
h Estrogen, NADPH, acetylcholine, serotonin, insulin, vinegar
SNP(s) Found:
NOS3/eNOS A(-922)G (+/-, AG) i
▪ This variant is theorized to decrease NOS3 activity.
▪ Associated symptoms and conditions may be ischemic stroke and limb defects in children
born to smoking mothers who do not supplement with vitamins during pregnancy.
COMT
The COMT (catechol-O-methyltransferase) gene encodes the COMT enzyme, which is an important
catabolic enzyme, especially in the prefrontal cortex, where it degrades catecholamines. Since the
COMT enzyme is involved in the degradation of catechol estrogens, genetic mutations that decrease
enzymatic activity can lead to elevations in catechol estrogens, which have been shown to damage
DNA and have carcinogenic potential. Higher levels of COMT enzymatic activity also result in
decreased levels of dopamine and norephinephrine.
Factors influencing COMT:

Cofactor: Mg2+
i Serotonin, anti-psychotic Rx, low folate or Vit D, estrogen, quercetin, EGCG, soy isoflavones,
TNF-alpha.
h Hypoxia, traumatic brain injury, LPS, L-dopa, testosterone. Progesterone may increase or
decrease activity depending on progesterone receptor distribution.
NOTE: COMT regulation has complex, tissue-specific, reciprocal relations with many
pathways in the body such as folate-homocysteine metabolism and
catecholestrogen metabolism. COMT V158M (rs4680) below is a good example of a
"trade-off" SNP where the "risk" allele, as well as wild or ancestral allele, can be
found to be epidemiologically risky or beneficial given environmental/epigenetic
factors.
SNP(s) Found:
COMT V158M (+/-, AG)
▪ This variant is associated with intermediate levels of COMT activity (vs. AA and GG). There
is mounting evidence this variant contributes to the most balanced metabolism of
neurotransmitters.
▪ May be protective against schizophrenia, and is associated with better outcomes in low
back pain compared to AA or GG types.
COMT H62H (+/-, CT) i
▪ This variant is likely associated with intermediate COMT activity due to reduced
expression relative to wild type (CC).
▪ The CT genotype was found to be protective for schizophrenia and had significantly better
outcomes in low back pain than CC or TT types.
C010232018 2.5 The Histamine Pathway Page 13 of 16
2.5 The Histamine Pathway

Histamine is a significant player in human health. The histamine pathway controls the regulation of
intracellular and extracellular histamine. Understanding how histamine is formed and metabolized
both intracellularly and extracellularly may provide significant findings in resolving health
complaints.
NH 4
Histidine H 20
Catecholamines, Benzene, Inflammation, LPS, B6 H 20
Infection, Bacteria, Histamine Containing Foods
HDC THF
(putrescine, spermine, spermidine) FIGLU Glutamate
FTCD
Histamine Storage 5-formiminoTHF
(intracellular) (Mast Cells, Neurons
Histamine Basophils)
(extracellular) NH 4
Amiloride SAH SAM Release
Cu, Ca, H 20, 02 NAT2 SLOW
DAO FTCD
HNMT Catecholamines,
H 2 0 + NH 3 Feedback CoA Inflammation, LPS,
FAD 2
Inhibition Infection, Bacteria,
Acetylhistamine 5, 10-MTHF
Imidazole acetylaldehyde Allergens, Injuries
N-Methylhistamine
Zn, Vit C, NAD, B1 FAD NADPH, H 20
Urine MTHFD1
ADH NADP
MAO B
10-formylTHF
Imidazole acetic acid (Purine Synthesis)
N-Methylimidazole acetylaldehyde (See Folate Pathway)
Zn, Vit C, NAD, B1
ADH
N-Methylimidazole acetic acid
C010232018 2.5 The Histamine Pathway Page 14 of 16
2.5.1 HISTAMINE PATHWAY SNPS
NAT2
The NAT2 (N-Acetyltransferase 2) gene encodes for an enzyme which is responsible for phase II
activation or detoxification of xenobiotics such as arylamines. NAT2 is also involved in the
acetylation of the neurotransmitter serotonin and compounds such as histamine. Polymorphisms in
this gene affect enzymatic activity and result in a categorization of rapid, intermediate, or slow
acetylators.
Factors influencing NAT2:

Cofactor: Acetyl CoA
i Acetaminophen, Cisplatin, Triazole, glycyrrhizic acid (licorice root), diallyl sulfide (garlic)
h Ezogabine, Chlorzoxazone
Predicted NAT2 Acetylator Phenotype:

SLOW (0.998731) i
▪ This phenotype implies slower clearance of various drugs, environmental chemicals, and
histamine.
▪ Individuals with slow acetylator status may have a difficulty with the clearance of various
drugs and chemicals, putting them at increased risk for various diseases such as cancer,
asthma, neurological disorders.
C010232018 Section 3: Bonus SNPs Page 15 of 16
Section 3: Bonus SNPs

Bonus SNPs are not represented in the Pathway Planner graphics, but may provide useful
additional information to assist patient care decisions. Note: Discussed below are SNPs for which a
notable genotype was found (usually +/+ and +/-).
BCO1 (PKD1L2) C754T (+/-, AG) i

AA females are 60% less efficient than GG at beta carotene conversion. AG females rate of
converson is 25% less efficient. Note: The intrinsic variability in the BCO1 activity is found in men as
well, presumably due to the same SNPs, but currently there is no published research that examines
a male population to investigate the impact. Consider Vitamin A supplementation especially in
vegan individuals.
BCO1 rs11645428 (+/-, AG) i
GG females are 50% less efficient at conversion than AA, with AG women in between. GG females
are 50% less efficient at conversion than AA, with AG women in between. Note: The intrinsic
variability in the BCO1 activity is found in men as well, presumably due to the same SNPs, but
currently there is no published research that examines a male population to investigate the impact.
Consider Vitamin A supplementation especially in vegan individuals.
BCO1 rs6564851 (+/-, GT) i
GG females are 50% less efficient at conversion than TT, with GT women in between. Note: The
intrinsic variability in the BCO1 activity is found in men as well, presumably due to the same SNPs,
but currently there is no published research that examines a male population to investigate the
impact. Consider Vitamin A supplementation especially in vegan individuals.
FUT2 rs601338 (-/-, GG)
Carriers of at least one G allele are secretors and are more likely to be B12 deficient. For more
information about secretor status see the work of Peter D'Adamo, ND
NQO1 rs1800566 (+/-, AG) i
AA individuals cannot convert ubiquinone to active ubiquinol, and AG 3x less efficient at conversion
than GG. Consider supplementing ubiquinol for AA/AG individuals. GG individuals should be fine
with ubiquinone.
HFE H63D (+/-, CG) i
GG individuals at risk of mild form of hereditary hemochromatosis; For clinical management of
hemochromatosis please see http://www.aafp.org/afp/2013/0201/p183.html .
PEMT 5465G>A (+/+, TT) i
TT decreases PEMT activity by approximately 30%. CT also decreases PEMT activity but not as
much as TT. A meta-analysis of all studies on NAFLD showed a significant association with TT
individuals, especially in Asian populations. In a large case-controlled study , CT and TT Caucasian
women with low betaine intake had 2x the risk for breast CA. A case controlled study showed
increased risk for Alzheimers in CT and TT Chinese women. It is theorized in humans with enough
choline from dietary sources, rs7946-TT is helpful as it spares methyl groups for other biological
activities. It is also theorized this SNP is selected for because it protects against disease, most
notably, malaria, via diminished choline in the human host which impairs the replication of the
malaria parasite. Consider supplementing with choline before and during pregnancy, and after
menopause.
C010232018 Section 3: Bonus SNPs Page 16 of 16
FADS1 (MYRF) rs174537 (+/+, GG) h

GG and GT individuals have higher than average arachidonic acid (AA), LDL and total cholesterol
levels due to upregulated elongation of omega 6 PUFAs to pro-inflammatory compounds. Consider
limiting dietary sources of omega-6 PUFAs, esp. AA.
VDR Taq1 (-/-, AA)
Ancestral allele (A) is reported here as minus (-) and mutated/derivative allele (G) as plus (+).
Regardless of allele inheritance (AA, AG, or GG), maintenance of optimal serum 25-hydroxy Vitamin
D levels is recommended. Evaluation of 1,25-hydroxy D status may also be warranted. (Also see the
FAQ for more information.)
VDR Bsm1 (-/-, CC)
Ancestral allele (C) is reported here as minus (-) and mutated/derivative allele (T) as plus (+).
Regardless of allele inheritance (CC, CT, or TT), maintenance of optimal serum 25-hydroxy Vitamin D
levels is recommended. Evaluation of 1,25-hydroxy D status may also be warranted. (Also see the
FAQ for more information.)
APOE genotype: APOE 3/4
More information on ApoE status can be found here (http://www.ncbi.nlm.nih.gov/pubmed/
19414656). Go to the free full text link, and scroll through the article to the section: "ApoE
Genotype".

Chelsi Strategene

Uploaded by

Copyright:

Available Formats

Chelsi Strategene

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Chelsi Strategene

Uploaded by

Copyright:

Available Formats

Although this report may provide useful diagnostic information, by providing this report,

Prepared For: C010232018

Symbols and Colors

Increases Activity Decreases Activity

Gene/Enzyme Gene/Enzyme Gene/Enzyme Gene/Enzyme

No SNP Data Wild Type Heterozygous SNP Homozygous SNP

Reduced Folates and Folic Acid

Folic acid, Dairy antibodies NADPH Folic acid

DHFR Unmetabolized Folic Acid

DHF Folic Acid, EGCG, GSE,

Thymidine dTMP organophosphates, NADP

Purines MTHFD1 Serine

DHA, Low Methionine, ALA SAM, CDR, ROS,

2.1.1 FOLATE CYCLE SNPS

Factors influencing SLC19a1:

Factors influencing MTHFD1:

2.2 The Methionine Cycle

NO, LPS, CCL4,

2.2.1 METHIONINE CYCLE SNPS

Factors influencing MTRR:

2.3 The Transsulfuration Pathway

2.3.1 TRANSSULFURATION PATHWAY SNPS

Factors influencing SOD2:

2.4 The Biopterin Pathway

2.4.1 BIOPTERIN PATHWAY SNPS

Factors influencing NOS3 (eNOS):

Factors influencing COMT:

2.5 The Histamine Pathway

Zn, Vit C, NAD, B1

N-Methylimidazole acetic acid

2.5.1 HISTAMINE PATHWAY SNPS

Factors influencing NAT2:

Predicted NAT2 Acetylator Phenotype:

Section 3: Bonus SNPs

BCO1 (PKD1L2) C754T (+/-, AG) i

FADS1 (MYRF) rs174537 (+/+, GG) h

You might also like